Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.

Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G.

Br J Psychiatry. 1999 Mar;174:213-8.

PMID:
10448445
2.

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.

Michelson D, Allgulander C, Dantendorfer K, Knezevic A, Maierhofer D, Micev V, Paunovic VR, Timotijevic I, Sarkar N, Skoglund L, Pemberton SC.

Br J Psychiatry. 2001 Dec;179:514-8.

3.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
4.
5.

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

Romano S, Goodman W, Tamura R, Gonzales J.

J Clin Psychopharmacol. 2001 Feb;21(1):46-52.

PMID:
11199947
6.
7.
8.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
9.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
10.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
11.

Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.

Joliat MJ, Schmidt ME, Fava M, Zhang S, Michelson D, Trapp NJ, Miner CM.

J Clin Psychiatry. 2004 Mar;65(3):373-8.

PMID:
15096077
12.

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

Stewart JW, Quitkin FM, McGrath PJ, Amsterdam J, Fava M, Fawcett J, Reimherr F, Rosenbaum J, Beasley C, Roback P.

Arch Gen Psychiatry. 1998 Apr;55(4):334-43.

PMID:
9554429
13.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
14.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005. Epub 2008 Nov 29.

PMID:
19042026
15.

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A.

Clin Ther. 2001 Jul;23(7):1040-58.

PMID:
11519769
16.

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.

Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.

Int Clin Psychopharmacol. 2008 Sep;23(5):269-75. doi: 10.1097/YIC.0b013e328301a74c.

PMID:
18703936
17.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
18.
19.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
20.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880

Supplemental Content

Support Center